Ardent Health Partners (ARDT) Competitors $12.38 +0.08 (+0.65%) As of 03:58 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock ARDT vs. HIMS, GH, OPCH, RDNT, PIII, SHC, BTSG, PRVA, WGS, and SGRYShould you be buying Ardent Health Partners stock or one of its competitors? The main competitors of Ardent Health Partners include Hims & Hers Health (HIMS), Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), P3 Health Partners (PIII), Sotera Health (SHC), BrightSpring Health Services (BTSG), Privia Health Group (PRVA), GeneDx (WGS), and Surgery Partners (SGRY). These companies are all part of the "healthcare" industry. Ardent Health Partners vs. Hims & Hers Health Guardant Health Option Care Health RadNet P3 Health Partners Sotera Health BrightSpring Health Services Privia Health Group GeneDx Surgery Partners Hims & Hers Health (NYSE:HIMS) and Ardent Health Partners (NYSE:ARDT) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, risk, institutional ownership, analyst recommendations, dividends, community ranking, valuation, earnings and profitability. Is HIMS or ARDT more profitable? Hims & Hers Health has a net margin of 8.19% compared to Ardent Health Partners' net margin of 0.00%. Hims & Hers Health's return on equity of 10.97% beat Ardent Health Partners' return on equity.Company Net Margins Return on Equity Return on Assets Hims & Hers Health8.19% 10.97% 8.29% Ardent Health Partners N/A N/A N/A Do analysts rate HIMS or ARDT? Hims & Hers Health currently has a consensus target price of $38.25, indicating a potential upside of 42.09%. Ardent Health Partners has a consensus target price of $20.58, indicating a potential upside of 66.26%. Given Ardent Health Partners' stronger consensus rating and higher probable upside, analysts plainly believe Ardent Health Partners is more favorable than Hims & Hers Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hims & Hers Health 2 Sell rating(s) 7 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.21Ardent Health Partners 0 Sell rating(s) 2 Hold rating(s) 9 Buy rating(s) 2 Strong Buy rating(s) 3.00 Does the media prefer HIMS or ARDT? In the previous week, Hims & Hers Health had 20 more articles in the media than Ardent Health Partners. MarketBeat recorded 28 mentions for Hims & Hers Health and 8 mentions for Ardent Health Partners. Hims & Hers Health's average media sentiment score of 0.73 beat Ardent Health Partners' score of 0.70 indicating that Hims & Hers Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 14 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Positive Ardent Health Partners 4 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community prefer HIMS or ARDT? Hims & Hers Health received 20 more outperform votes than Ardent Health Partners when rated by MarketBeat users. However, 88.46% of users gave Ardent Health Partners an outperform vote while only 36.44% of users gave Hims & Hers Health an outperform vote. CompanyUnderperformOutperformHims & Hers HealthOutperform Votes4336.44% Underperform Votes7563.56% Ardent Health PartnersOutperform Votes2388.46% Underperform Votes311.54% Do institutionals & insiders have more ownership in HIMS or ARDT? 63.5% of Hims & Hers Health shares are held by institutional investors. 17.7% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has better valuation & earnings, HIMS or ARDT? Ardent Health Partners has higher revenue and earnings than Hims & Hers Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHims & Hers Health$1.48B4.05-$23.55M$0.5449.85Ardent Health Partners$5.97B0.30$53.90MN/AN/A SummaryHims & Hers Health beats Ardent Health Partners on 9 of the 16 factors compared between the two stocks. Remove Ads Get Ardent Health Partners News Delivered to You Automatically Sign up to receive the latest news and ratings for ARDT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ARDT vs. The Competition Export to ExcelMetricArdent Health PartnersGeneral medical & surgical hospitals IndustryMedical SectorNYSE ExchangeMarket Cap$1.77B$10.92B$5.28B$18.33BDividend YieldN/A0.65%5.11%4.23%P/E RatioN/A4.5921.6330.99Price / Sales0.300.51371.0825.38Price / CashN/A6.8638.1517.53Price / BookN/A30.766.374.26Net Income$53.90M$1.06B$3.20B$1.02B7 Day Performance-2.13%-3.44%1.79%-1.29%1 Month Performance-11.16%-4.16%-9.41%-7.34%1 Year PerformanceN/A5.30%9.61%1.23% Ardent Health Partners Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ARDTArdent Health PartnersN/A$12.38+0.7%$20.58+66.3%N/A$1.77B$5.97B0.0024,200HIMSHims & Hers Health3.5705 of 5 stars$28.21+3.6%$38.25+35.6%+123.0%$6.27B$1.48B64.12650Gap DownGHGuardant Health3.6764 of 5 stars$45.16+3.3%$49.00+8.5%+162.9%$5.57B$739.02M-12.691,790OPCHOption Care Health3.1393 of 5 stars$31.84+0.9%$33.00+3.6%+4.4%$5.23B$5.00B26.765,600Short Interest ↑Positive NewsHigh Trading VolumeRDNTRadNet3.815 of 5 stars$53.36-0.1%$69.75+30.7%+11.0%$3.95B$1.83B-762.188,970News CoveragePositive NewsGap DownPIIIP3 Health Partners1.6225 of 5 stars$8.99+18.6%$0.25-97.2%-60.3%$3.23B$1.50B-10.70500News CoverageHigh Trading VolumeSHCSotera Health2.406 of 5 stars$10.62+1.0%$15.20+43.1%-4.6%$3.01B$1.10B42.483,000Gap DownBTSGBrightSpring Health Services2.905 of 5 stars$17.10+0.1%$21.67+26.7%+64.4%$2.99B$11.27B-65.7735,000News CoveragePositive NewsPRVAPrivia Health Group3.7651 of 5 stars$24.05-0.2%$26.87+11.7%+31.8%$2.92B$1.74B240.52810Analyst ForecastPositive NewsGap DownWGSGeneDx1.9675 of 5 stars$101.04+4.6%$72.33-28.4%+934.6%$2.84B$305.45M-51.551,200Positive NewsGap DownSGRYSurgery Partners2.7454 of 5 stars$21.32+1.6%$36.63+71.8%-17.9%$2.72B$3.11B-44.4213,500Positive News Remove Ads Related Companies and Tools Related Companies HIMS Competitors GH Competitors OPCH Competitors RDNT Competitors PIII Competitors SHC Competitors BTSG Competitors PRVA Competitors WGS Competitors SGRY Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ARDT) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredFirst look: The $3,500 iPhoneDid you hear that just before Trump's tariffs took effect, Apple sent five cargo planes packed with MacBooks a...Stansberry Research | SponsoredMarkets in Chaos? Here’s What to Do.Wall Street's on edge with tariffs. And volatility? It's not slowing down. You've seen the headlines… Bu...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ardent Health Partners, LLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Ardent Health Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.